DavidAllanEberhardMDPhD
Pathology • Carrboro, NCMolecular Genetics, Neuropathology, Anatomic Pathology, Clinical Pathology
Senior Director of Oncology Development, Genomic Health Inc, Redwood City, CA Associate Professor, Pathology & Laboratory Medicine, University of North Carolina at Chapel Hill School of Medicine
Dr. Eberhard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
105 E Poplar Ave
Carrboro, NC 27510Phone+1 919-928-4087
Education & Training
University of Michigan Medical SchoolClass of 1990
University of Virginia Medical CenterResidency, Pathology-Anatomic and Clinical
Certifications & Licensure
NC State Medical License 2009 - 2025
CA State Medical License 2016 - 2024
VA State Medical License 1996 - 2020- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- 88 citationsCriteria for the use of omics-based predictors in clinical trials: explanation and elaboration.Lisa M. McShane, Margaret M. Cavenagh, Tracy Lively, David A. Eberhard, William L. Bigbee
BMC Medicine. 2013-10-17 - 172 citationsCriteria for the use of omics-based predictors in clinical trialsLisa M. McShane, Margaret M. Cavenagh, Tracy Lively, David A. Eberhard, William L. Bigbee
Nature. 2013-10-17 - 789 citationsDiverse somatic mutation patterns and pathway alterations in human cancersZhengyan Kan, Bijay S. Jaiswal, Jeremy Stinson, Vasantharajan Janakiraman, Deepali Bhatt
Nature. 2010-08-12
Press Mentions
Liquid Biopsies Guide the Development of Cancer DrugsSeptember 6th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
